hydrocodone bitartrate and acetaminophen tablet

INDICATIONS AND USAGE Hydrocodone bitartrate and acetaminophen tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, which can occur at any dosage or duration [see WARNINGS ], reserve hydrocodone bitartrate and acetaminophen tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): have not been tolerated or are not expected to be tolerated, have not provided adequate analgesia or are not expected to provide adequate analgesia Hydrocodone bitartrate and acetaminophen tablets should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate.

kvk-tech, inc.

FDA Reported Adverse Reactions
`[1] drug dependence` `[2] pain` `[3] overdose` `[4] fatigue` `[5] drug ineffective` `[6] emotional distress` `[7] nausea` `[8] off label use` `[9] death` `[10] headache`

6 years ago

OVAL WHITE A 42

HOW SUPPLIED

HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablets, USP are supplied as: 5 mg/300 mg white to off-white, capsule shaped, biconvex tablets, debossed ‘A 41’ with break line on one side and plain on the other side. Bottles of 30 tablets NDC 10702-192-03 Bottles of 100 tablets NDC 10702-192-01 Bottles of 500 tablets NDC 10702-192-50 Bottles of 1000 tablets NDC 10702-192-10 7.5 mg/300 mg white to off-white, capsule shaped, biconvex tablets, debossed ‘A 42’ with break line on one side and plain on the other side. Bottles of 30 tablets NDC 10702-193-03 Bottles of 100 tablets NDC 10702-193-01 Bottles of 500 tablets NDC 10702-193-50 Bottles of 1000 tablets NDC 10702-193-10 10 mg/300 mg white to off-white, capsule shaped, biconvex tablets, debossed ‘A 43’ with break line on one side and plain on the other side. Bottles of 30 tablets NDC 10702-194-03 Bottles of 100 tablets NDC 10702-194-01 Bottles of 500 tablets NDC 10702-194-50 Bottles of 1000 tablets NDC 10702-194-10 5 mg/325 mg white to off-white, capsule shaped, biconvex tablets, debossed ‘A 38’ with break line on one side and plain on the other side. Bottles of 30 tablets NDC 10702-189-03 Bottles of 100 tablets NDC 10702-189-01 Bottles of 500 tablets NDC 10702-189-50 Bottles of 1000 tablets NDC 10702-189-10 7.5 mg/325 mg white to off-white, capsule shaped, biconvex tablets, debossed ‘A 39’ with break line on one side and plain on the other side. Bottles of 30 tablets NDC 10702-190-03 Bottles of 100 tablets NDC 10702-190-01 Bottles of 500 tablets NDC 10702-190-50 Bottles of 1000 tablets NDC 10702-190-10 10 mg/325 mg white to off-white, capsule shaped, biconvex tablets, debossed ‘A 40’ with break line on one side and plain on the other side. Bottles of 30 tablets NDC 10702-191-03 Bottles of 100 tablets NDC 10702-191-01 Bottles of 500 tablets NDC 10702-191-50 Bottles of 1000 tablets NDC 10702-191-10 Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature]. Store

HYDROCODONE BITARTRATE AND ACETAMINOPHEN tablets securely and dispose of properly [see PRECAUTIONS;Information for Patients ]. Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Manufactured by: KVK-Tech, Inc. 110 Terry Drive Newtown, PA 18940 Item ID #: 6283/11 Rev.: 01/2024 logo

More pills like OVAL A 42

Related Pills

Acetaminophen 325 MG Hydrocodone Bitartrate 7.5 MG Oral Tablet

KVK-Tech, Inc.

hydrocodone bitartrate and acetaminophen tablet

kvk-tech, inc.

hydrocodone bitartrate and acetaminophen tablet

kvk-tech, inc.

celecoxib capsule

cipla usa inc.

cephalexin capsule

aurobindo pharma limited

pregabalin 50 mg

REMEDYREPACK INC.

celecoxib 200 mg

Cipla USA Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site